欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
PL/H/0568/001
药品名称
Apiprax
活性成分
aripiprazole 15.0 mg
剂型
Tablet
上市许可持有人
Aristo Pharma Sp. z o.o. ul. Baletowa 30 02-867 Warszawa Poland
参考成员国 - 产品名称
Poland (PL)
Apiprax
互认成员国 - 产品名称
许可日期
2016/02/05
最近更新日期
2024/07/17
药物ATC编码
N05AX12 aripiprazole
申请类型
TypeLevel1:
[not specified]
TypeLevel2:
[not specified]
TypeLevel3:
[not specified]
TypeLevel4:
[not specified]
TypeLevel5:
[not specified]
附件文件下载
Final Product Information
|
common_pl_proposed_track OLD M__corr10012022
Date of last change:2022/06/02
Final Product Information
|
common_pl_proposed_track OLD M__corr10012022_2
Date of last change:2022/06/02
Final Product Information
|
PL_H_0568_001_IB_013_ Apiprax_ approval
Date of last change:2022/06/02
Final Product Information
|
common_spc_proposed_track_ OLD M__corr10012022
Date of last change:2022/06/02
Final Product Information
|
common_spc_proposed_track_ OLD M__corr10012022_2
Date of last change:2022/06/02
Final PL
|
common-pl-proposed-track
Date of last change:2020/07/16
Final SPC
|
common-spc-proposed-track OLD
Date of last change:2020/07/16
Final Labelling
|
common-outer-track
Date of last change:2020/05/19
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase